Trial intelligence / Profile preview

L-carnitine replacement algorithm in maintenance hemodialysis patients with ESA-resistant anemia

jRCT1090220256Recruiting

Sponsor
shogo kimura
Start
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of levocarnitine in anaemia, sponsored by shogo kimura. Primary endpoints: Change in red blood cell count, Change in hemoglobin and 7 more. Started Jul 2016; status: recruiting.

02

Drugs

levocarnitine
03

Conditions

anaemia

Beyond the preview

Go deeper on jRCT1090220256.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1090220256.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call